首页> 外国专利> PROCESS FOR PREPARING A PHARMACEUTICAL OR VETERINARY PREPARATION WITH SEDATIVE AND / OR MUSCLE-RELAXING ACTION BASED ON A 1-SUBSTITUTED-6- -PENYL-4H-S-TRIAZOLOŸ4,3, -AŸŸ1,4Ÿ-SUBVODASAPINE OBJECTED PREPARED PREPARATION AND METHOD FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING PROCESS.

PROCESS FOR PREPARING A PHARMACEUTICAL OR VETERINARY PREPARATION WITH SEDATIVE AND / OR MUSCLE-RELAXING ACTION BASED ON A 1-SUBSTITUTED-6- -PENYL-4H-S-TRIAZOLOŸ4,3, -AŸŸ1,4Ÿ-SUBVODASAPINE OBJECTED PREPARED PREPARATION AND METHOD FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING PROCESS.

机译:基于1-取代的6--PENYL-4H-S-三唑基4,3,-AŸŸ1,4Ÿ-Subvodasapane反对的制备和方法,采用去饱和和/或放松肌肉的作用制备药物或兽药的方法适合在上述过程中使用的化合物。

摘要

1331419 Triazolo-benzodiazepine derivatives UPJOHN CO 29 March 1972 [28 April 1971] 14878/72 Heading C2C Novel compounds of the Formula VI wherein R is chloro, bromo, cyano, C 1-3 alkoxy, di-(C 1-3 alkyl) amino, pyrrolidino, piperidino or morpholino; R 1 is hydrogen or C 1-3 alkyl; R 2 , R 3 , R 4 and R 5 are hydrogen, C 1-3 alkyl, fluoro, chloro, bromo, nitro, cyano, trifluoromethyl or C 1-3 alkoxy, alkylthio, alkylsulphinyl or alkylsulphanyl and salts thereof may be prepared (a) where R is chloro or bromo by reacting the 1-unsubstituted compound with N-chloro or N-bromo-succinimide; (b) where R is cyano, by reacting the 1-bromo compound with cuprous cyanide; and (c) where R is C 1-3 alkoxy or di- (C 1-3 alkyl) amino, pyrrolidino, piperidino or morpholine, by reacting the products of (a) with sodium or potassium C 1-3 alkoxide in C 1-3 alkanol or with the appropriate amine respectively. The intermediates of the Formula I may be prepared by reacting the appropriate 1,3 - dihydro - 5 - phenyl - 2H - 1,4 - benzodiazepine - 2 - thiones with formic acid hydrazide. Pharmaceutical compositions of the compounds VI show sedative, tranquilizing and muscle relazant activity when administered orally, parenterally or rectally with the usua 1 excipients.
机译:1331419三唑-苯并二氮杂卓衍生物UPJOHN CO 1972年3月29日[1971年4月28日]标题为C2C新型的式VI化合物,其中R为氯,溴,氰基,C 1-3烷氧基,二-(C 1-3烷基)氨基,吡咯烷基,哌啶子基或吗啉代; R 1为氢或C 1-3烷基; R 2,R 3,R 4和R 5为氢,C 1-3烷基,氟,氯,溴,硝基,氰基,三氟甲基或C 1-3烷氧基,烷硫基,烷基亚磺酰基或烷基磺酰基及其盐可以制备( a)通过使1-未取代的化合物与N-氯或N-溴-琥珀酰亚胺反应,R为氯或溴; (b)当R是氰基时,使1-溴化合物与氰化亚铜反应; (c)其中R为C 1-3烷氧基或二-(C 1-3烷基)氨基,吡咯烷基,哌啶子基或吗啉,通过使(a)的产物与C 1-3的钠或钾的C 1-3醇盐反应-3链烷醇或分别与适当的胺。式I的中间体可以通过使合适的1,3-二氢-5-苯基-2H-1,4-苯二氮杂-2--2-硫酮与甲酸酰肼反应来制备。当与usua 1赋形剂口服,胃肠外或直肠给药时,化合物VI的药物组合物显示出镇静,镇静和肌肉松弛作用。

著录项

  • 公开/公告号NL165742B

    专利类型

  • 公开/公告日1980-12-15

    原文格式PDF

  • 申请/专利号NL19720005630

  • 发明设计人

    申请日1972-04-26

  • 分类号C07D487/04;A61K31/55;

  • 国家 NL

  • 入库时间 2022-08-22 16:11:03

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号